PRIMARY HEADACHES IN ADOLESCENTS WITH DEPENDENCE ON COMPUTER GAMES AND SOCIAL NETWORKS. APPROACHES TO THE TREATMENT AND PREVENTION OF MIGRAINE IN CHILDREN AND ADOLESCENTS

DOI: https://doi.org/10.29296/25877305-2023-06-03
Issue: 
6
Year: 
2023

Yu. Kostyuchenko(1); T. Potupchik(2), Сandidate of Medical Sciences; L. Evert(1, 3), MD; M. Shubina(1); O. Chudinova(3), Candidate of Biological Sciences
1-Federal Research Center «Krasnoyarsk Scientific Center of the Siberian Branch
of the Russian Academy of Sciences», Research Institute of Medical Problems
of the North
2-Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry
of Health of Russia
3-N.F. Katanov Khakass State University, Ministry of Education and Science
of Russia, Abakan

A review of data on the main types of primary cephalgia in adolescents (headache tension and migraine), their prevalence, classification, clinical manifestations, basic principles of treatment and prevention is presented. The results of our own study, which showed a closer relationship between the frequency of occurrence and clinical features of these types of pathology with the presence of addiction to computer games and social networks in adolescents, are included. Of the 5195 surveyed adolescents, 8.1% had an to social media addiction, 10.5% had a Gaming Addiction, including 7.7% moderate and 2.8% severe. The authors come to the conclusion that it is necessary to analyze the characteristics of Internet use and content consumed by adolescents for early diagnosis, treatment and prevention of primary cephalalgia associated with the presence of gaming addiction and dependence on social networks, highlight approaches to the treatment of migraine in adolescents.
Keywords: 
adolescents
headaches
migraine
tension headache
gambling addiction
social media addiction
migraine treatment.

References: 
  1. Алиджанова Д.А., Маджидова Е.Н., Нурмухамедова М.А. Патогенетические механизмы развития головной боли напряжения у детей и принципы ее профилактики. Сибирское медицинское обозрение. 2017; 1: 5–10. [Alidzhanova D.A., Majidova E.N., Nurmukhamedova M.A. Pathogenetic mechanisms of tension headache development in children and principles of its prevention. Siberian Medical Review. 2017; 1: 5–10 (in Russ.)]. DOI: 10.20333/2500136-2017-1-5-10
  2. Головачева В.А., Головачева А.А. Антоненко Л.М. Мигрень у детей и подростков: современные принципы диагностики и лечения. Неврология, нейропсихиатрия, психосоматика. 2021; 13 (6): 111–6 [Golovacheva V.A., Golovacheva A.A. Antonenko L.M. Migraine in children and adolescents: modern principles of diagnosis and treatment. Neurology, neuropsychiatry, psychosomatics. 2021; 13 (6): 111–6 (in Russ.)]. DOI: 10.14412/2074-2711-2021-6-111-116
  3. Есин Р.Г., Есин О.Р., Шамсутдинова Р.Ф. Современные подходы к коррекции дезадаптационных (психовегетативных) расстройств у детей и подростков с головной болью напряжения. Педиатрия им. Г.Н. Сперанского. 2015; 94 (1): 106–12 [Yesin R.G., Yesin O.R., Shamsutdinova R.F. Modern approaches to the correction of maladaptation (psychovegetative) disorders in children and adolescents with tension headache. Pediatrics named after G.N. Speransky. 2015; 94 (1): 106–12 (in Russ.)].
  4. Заваденко Н.Н. Первичные головные боли у детей и подростков: учебно-методическое пособие. М.: ГБОУ ВПО РНИМУ им. Н.И. Пирогова Минздрава России, 2015 [Zavadenko N.N. Primary headaches in children and adolescents: an educational and methodological manual. M.: GBOU VPO RNIMU named after N.I. Pirogov of the Ministry of Health of Russia, 2015 (in Russ.)].
  5. Кондратьева А.В., Шнайдер Н.А., Шульмин А.В. Эпидемиология головных болей. Современные проблемы науки и образования. 2015; 6: 23 [Kondratieva A.V., Schneider N.A., Shulmin A.V. Epidemiology of headaches. Modern problems of science and education. 2015; 6: 23 (in Russ.)].
  6. Кукушкин А.В. Применение фитопрепарата «НЕРВО-ВИТ» в лечении пациентов с психовегетативным синдромом. Неврология/ревматология. Спецвыпуск. 2017; 3: 29–32 [Kukushkin A.V. The use of the phytopreparation "NERVO-VIT" in the treatment of patients with psychovegetative syndrome. Neurology/Rheumatology. Special Issue. 2017; 3: 29–32 (in Russ.)].
  7. Сергеев А.В., Екушева Е.В. Мигрень у детей. Особенности диагностики и современные возможности терапии. РМЖ. Медицинское обозрение. 2018; 2 (9): 26–32 [Sergeev A.V., Ekusheva E.V. Migraine in children. Features of diagnostics and modern possibilities of therapy. RMJ. Medical Review. 2018; 2 (9): 26–32 (in Russ.)].
  8. Федеральные клинические рекомендации (протоколы) по диагностике и лечению мигрени у детей. 2013. [Federal clinical guidelines (protocols) for the diagnosis and treatment of migraine in children. 2013. (in Russ.)].
  9. Шагбазян А.Э., Евдокимова Е.М., Табеева Г.Р. Клинический анализ триптанов для купирования приступов мигрени. РМЖ. 2017; 9: 660–3 [Shakhbazyan A.E., Evdokimova E.M., Tabeeva G.R. Clinical analysis of triptans for the relief of migraine attacks. RMJ. 2017; 9: 660–3 (in Russ.)].
  10. Al-Hashel J.Y., Ahmed S.F., Alroughani R. Prevalence of Primary Headache Disorders in Kuwait. Neuroepidemiology. 2017; 48 (3-4): 138–46. DOI: 10.1159/000478892
  11. Balch P.A. Prescription for nutritional healing (A practical A-to-Z reference to drug-free remedies using vitamins, minerals, herbs & food supplements). 4th ed. New York. Avery. A member of Penguin Group (USA) Inc., 2006.
  12. Blume H.K. Childhood headache: a brief review. Pediatric Annals. 2017; 46 (4): e155–e165. DOI: 10.3928/19382359-20170321-02
  13. Burstein R., Collins B., Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneus allodynia. Ann Neurol. 2004; 55: 19–26. DOI: 10.1002/ana.10786
  14. Cavestro C., Montrucchio F., Benci P. et al. Headache prevalence and related symptoms, family history, and treatment habits in a representative population of children in Alba, Italy. Pediatr Neurol. 2014; 51: 348–53. DOI: 10.1016/j.pediatrneurol.2014.05.022
  15. Genizi J., Srugo I., Kerem C.N. The cross-ethnic variations in the prevalence of headache and other somatic complaints among adolescents in Northern Israel. J Headache Pain. 2013; 14 (1): 21. DOI: 10.1186/1129-2377-14-21
  16. Gotlib D., Ramaswamy R., Kurlander J.E. et al. Valproic Acid in Women and Girls of Childbearing Age. Curr Psychiatry Rep. 2017; 19 (9): 58. DOI: 10.1007/s11920-017-0809-3
  17. Greene K.A., Gentile C.P., Szperka C.L. et al. Calcitonin Gene-Related Peptide Monoclonal Antibody Use for the Preventive Treatment of Refractory Headache Disorders in Adolescents. Pediatr Neurol. 2021; 114: 62–7. DOI: 10.1016/j.pediatrneurol.2020.09.014
  18. Greene K., Irwin S.L., Gelfand A.A. Pediatric Migraine: An Update. Neurol Clin. 2019; 37 (4): 815–33. DOI: 10.1016/j.ncl.2019.07.009
  19. Hu C., Zhang Y., Tan G. Advances in topiramate as prophylactic treatment for migraine. Brain Behav. 2021; 11 (10): e2290. DOI: 10.1002/brb3.2290
  20. Kacperski J., Green A., Qaiser S. Management of Chronic Migraine in Children and Adolescents: A Brief Discussion on Preventive Therapies. Paediatr Drugs. 2020; 22 (6): 635–43. DOI: 10.1007/s40272-020-00418-y
  21. Kacperski J., Hershey A.D. Newly Approved Agents for the Treatment and Prevention of Pediatric Migraine. CNS Drugs. 2016; 30 (9): 837–44. DOI: 10.1007/s40263-016-0375-y
  22. Lemmens J.S., Valkenburg P.M., Peter J. Development and Validation of a Game Addiction Scale for Adolescents. Media Psychology. 2009; 12 (1): 77–95. DOI: 10.1080/15213260802669458
  23. Lisicki M., Schoenen J. Metabolic treatments of migraine. Expert Rev Neurother. 2020; 20 (3): 295–302. DOI: 10.1080/14737175.2020.1729130
  24. Orr S.L., Potter B.K., Ma J. et al. Migraine and mental health in a population-based sample of adolescents. Can J Neurol Sci. 2017; 44 (1): 44–50. DOI: 10.1017/cjn.2016.402
  25. Powers S.W., Kashikar-Zuck S.M., Allen J.R. et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013; 310 (24): 2622–30. DOI: 10.1001/jama.2013.282533
  26. Rho Y.I., Chung H.J., Lee K.H. Prevalence and clinical characteristics of primary headaches among school children in South Korea: a nationwide survey. Headache. 2012; 52 (4): 592–9. DOI: 10.1111/j.1526-4610.2011.02001.x
  27. Shikov A., Pozharitskaya O., Makarov V. et al. Effect of Leonurus cardiac oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders. Phytother Res. 2011; 25 (4): 540–3. DOI: 10.1002/ptr.3292
  28. Szperka C. Headache in Children and Adolescents. Continuum (Minneap Minn). 2021; 27 (3): 703–31. DOI: 10.1212/CON.0000000000000993
  29. Szperka C.L., Van der Pluym J., Orr S.L. et al. Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents. Headache. 2018; 58 (10): 1658–69. DOI: 10.1111/head.13414
  30. Tajti J., Szok D., Csáti A. et al. Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update. Curr Pain Headache Rep. 2016; 20 (1): 1. DOI: 10.1007/s11916-015-0536-6
  31. Tekin H., Edem P. Effects and side effects of migraine prophylaxis in children. Pediatr Int. 2022; 64 (1): e15094. DOI: 10.1111/ped.15094
  32. The International Classification of Headache Disorders, 3rd Edition (beta version). Headache Classification Committee of the International Headache Society. Cephalalgia. 2013; 33 (9): 629–808. DOI: 10.1177/0333102413485658
  33. Van Den Eijnden R.J.J.M., Lemmens J.S., Valkenburg P.M. The Social Media Disorder Scale: Validity and psychometric properties. Comput Human Behav. 2016; 61 (3): 478–87. DOI: 10.1016/j.chb.2016.03.038
  34. Vogler K., Gren C., Debes N.M. et al. Diagnosis and treatment of migraine in children and adolescents. Ugeskr Laeger. 2018; 180 (10): V06170484.
  35. Wöber-Bingöl Ç, Wöber C., Uluduz D. et al. The global burden of headache in children and adolescents – developing a questionnaire and methodology for a global study. J Headache Pain. 2014; 15: 86. DOI: 10.1186 / 1129-2377-15-86